1. Cancer Facts & Figures [Webpage] . Key statistics for soft tissue sarcomas, https://www.cancer.org/cancer/soft-tissue-sarcoma/about/key-statistics.html#references (2020, accessed 16 August 2020).
Google Scholar2. Nielsen, OS, Judson, I, van Hoesel, Q, et al. Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer 2000; 36(1): 61–67.
Google Scholar | Crossref | Medline | ISI3. Palumbo, R, Palmeri, S, Antimi, M, et al. Phase II study of continuous-infusion high-dose ifosfamide in advanced and/or metastatic pretreated soft tissue sarcomas. Ann Oncol 1997; 8(11): 1159–1162.
Google Scholar | Crossref | Medline4. Maki, RG, Wathen, JK, Patel, SR, et al. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]. J Clin Oncol 2007; 25(19): 2755–2763.
Google Scholar | Crossref | Medline | ISI5. Harris, SJ, Maruzzo, M, Thway, K, et al. Metastatic soft tissue sarcoma, an analysis of systemic therapy and impact on survival. J Clin Oncol 2015; 33(15_suppl): 10545.
Google Scholar | Crossref6. Leahy, M, Garcia Del Muro, X, Reichardt, P, et al. Chemotherapy treatment patterns and clinical outcomes in patients with metastatic soft tissue sarcoma. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study. Ann Oncol 2012; 23(10): 2763–2770.
Google Scholar | Crossref | Medline7. Gottlieb, JA, Benjamin, RS, Baker, LH, et al. Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Cancer Treat Rep 1976; 60(2): 199–203.
Google Scholar | Medline8. Gottlieb, JA, Baker, LH, Quagliana, JM, et al. Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide. Cancer 1972; 30(6): 1632–1638.
Google Scholar | Crossref | Medline9. Zucali, PA, Bertuzzi, A, Parra, HJ, et al. The “old drug” dacarbazine as a second/third line chemotherapy in advanced soft tissue sarcomas. Investig New Drugs 2008; 26(2): 175–181.
Google Scholar | Crossref | Medline10. Demetri, GD, von Mehren, M, Jones, RL, et al. Efficacy and safety of trabectedin or dacarbazine for metastatic liposarcoma or leiomyosarcoma after failure of conventional chemotherapy: results of a phase III randomized multicenter clinical trial. J Clin Oncol 2016; 34(8): 786–793.
Google Scholar | Crossref | Medline11. Schöffski, P, Maki, RG, Italiano, A, et al. Randomized, open-label, multicenter, phase III study of eribulin versus dacarbazine in patients (pts) with leiomyosarcoma (LMS) and adipocytic sarcoma (ADI). J Clin Oncol 2015; 33(18_suppl): LBA10502.
Google Scholar | Crossref12. Therasse, P, Arbuck, SG, Eisenhauer, EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92(3): 205–216.
Google Scholar | Crossref | Medline13. Young, H, Baum, R, Cremerius, U, et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. Eur J Cancer 1999; 35(13): 1773–1782.
Google Scholar | Crossref | Medline | ISI14. Lim, HJ, Johnny Ong, CA, Tan, JW, et al. Utility of positron emission tomography/computed tomography (PET/CT) imaging in the evaluation of sarcomas: a systematic review. Crit Rev Oncol Hematol 2019; 143: 1–13.
Google Scholar | Crossref | Medline15. Angelini, A, Castellucci, P, Ceci, F. Future perspective of the application of positron emission tomography-computed tomography-MR imaging in musculoskeletal disorders. PET Clin 2019; 14(1): 183–191.
Google Scholar | Crossref | Medline16. Muheremu, A, Ma, J, Amudong, A, et al. Positron emission tomography/computed tomography for osseous and soft tissue sarcomas: a systematic review of the literature and meta-analysis. Mol Clin Oncol 2017; 7(3): 461–467.
Google Scholar | Crossref | Medline